NCT01231672

Brief Summary

A prognostic score was proposed by the investigative team to predict death at 1 month. This score is based on certain biological markers, scored under emergency conditions in the first 24 hours of routine clinical practice management for septic shock. The main objective of this multicenter study is to validate the performance of the score in terms of area under the ROC curve and negative predictive value.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
780

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2009

Longer than P75 for all trials

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

October 29, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 1, 2010

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2013

Completed
Last Updated

November 17, 2025

Status Verified

March 1, 2015

Enrollment Period

4.6 years

First QC Date

October 29, 2010

Last Update Submit

November 14, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • AUC of the studied prognostic score

    The biological parameters measured at the time of admission to the intensive care unit and that make up the prognostic score for death at 1 month will be collected. The event "death within 1 month" will be analyzed. For patients discharged from service before the end of the first month, the clinician will still be informed concerning possible death. The studied biological parameters correspond to routine coagulation and hematological parameters for patients in septic shock, according to SFAR (Société Française d'Anesthésie et de Réanimation) recommendations and the SRLF (Société de Réanimation de Langue Française) Consensus (2002).

    24 hours (studied score parameters); 1 month (mortality)

  • Negative predictive value of the studied prognostic score

    The biological parameters measured at the time of admission to the intensive care unit and that make up the prognostic score for death at 1 month will be collected. The event "death within 1 month" will be analyzed. For patients discharged from service before the end of the first month, the clinician will still be informed concerning possible death. The studied biological parameters correspond to routine coagulation and hematological parameters for patients in septic shock, according to SFAR (Société Française d'Anesthésie et de Réanimation) recommendations and the SRLF (Société de Réanimation de Langue Française) Consensus (2002).

    24 hours (studied score parameters); 1 month (mortality)

Secondary Outcomes (4)

  • AUC of the studied prognostic score

    24 hours (studied score parameters); 1 week (mortality)

  • Negative predictive value of the studied prognostic score

    24 hours (studied score parameters); 1 week (mortality)

  • AUC of the studied prognostic score

    24 hours (studied score parameters); 5 days (DIC)

  • Negative predictive value for the studied prognostic score

    24 hours (studied score parameters); 5 days (DIC)

Study Arms (1)

Septic shock patients

Biological: Routine biological analyses

Interventions

Bilirubinemia (total and conjugated), hematology, hemogram, SOFA score

Septic shock patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Severe septic shock patients entering intensive care units in the participating centers.

You may qualify if:

  • patient (or representative) received the information notice
  • patient has hemodynamic insufficiency of non-traumatic or cardiogenic origin associated with severe sepsis (treated with Noradrenalin) and organ dysfunction, hypoperfusion or hypotension
  • body temperature \> 38.3°C or \< 36°C
  • heart rate \> 90 bpm
  • Tachypnea \> 20 C/min or PaCO2 \< 32 mmHg or mechanical ventilation
  • leukocytes \> 12000 µL-1 ou \< 4000 µL-1 ou \> 10% immature forms
  • oliguria \< 0.5 ml/kg/h for at least 2 hours
  • abrupt alteration (24 h) of conscienceness
  • thrombocytopenia \< 100 000 G/L or disseminated intravascular coagulation
  • mottled skin and / or capillary refill time\> 3 sec
  • PaO2/FiO2 \< 300 mmHg ou \< 40KPas
  • Lactatemia \> 2mMol/l
  • septic shock: Systolic Blood Pressure (SBP) \> 90 mmHg or need for vasopressors to maintain SBP\> 90 mmHg despite a prior filling (20-30 ml / kg of macromolecules or 40 to 60 ml / kg of normal saline (or decrease in SBP\> 40% in the hypertensive)

You may not qualify if:

  • patient is dying or limitation or cessation of active treatment
  • patient is already included in another trial
  • patient or family refusal
  • patient not affiliated with a social security system

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

CHU de Clermont Ferrand - Hôpital Estaing

Clermont-Ferrand, 63003, France

Location

APHM - Hôpital de la Conception

Marseille, 13385, France

Location

AP-HM Hôpital Nord

Marseille, 13915, France

Location

Centre Hospitalier Universitaire de Montpellier

Montpellier, France

Location

CHU de Nice

Nice, France

Location

Centre Hospitalier Universitaire de Nîmes

Nîmes, 30029, France

Location

CHU de Saint Etienne

Saint-Etienne, 42055, France

Location

Related Publications (1)

  • Gris JC, Faillie JL, Cochery-Nouvellon E, Lissalde-Lavigne G, Lefrant JY. ISTH overt disseminated intravascular coagulation score in patients with septic shock: automated immunoturbidimetric soluble fibrin assay vs. D-dimer assay. J Thromb Haemost. 2011 Jun;9(6):1252-5. doi: 10.1111/j.1538-7836.2011.04270.x. No abstract available.

MeSH Terms

Conditions

Shock, Septic

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • Géraldine Lavigne-Lissalde, MD

    Centre Hospitalier Universitaire de Nîmes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 29, 2010

First Posted

November 1, 2010

Study Start

April 1, 2009

Primary Completion

October 30, 2013

Study Completion

October 30, 2013

Last Updated

November 17, 2025

Record last verified: 2015-03

Locations